Drugs / SIZOFIRAN
SIZOFIRAN
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01926821 | May 2013 → Dec 2025 | cervical cancer | Asan Medical Center | Unknown | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SIZOFIRAN | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107997 ↗ |
| Known as | Mc-glucan | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107997 ↗ |
| Known as | Schizophyllan | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107997 ↗ |
| Known as | Schizophyllane | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107997 ↗ |
| Known as | Sixofilan | ChEMBL registry synonym — accepted as the source's own label CHEMBL2107997 ↗ |
| Known as | Sonifilan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01926821 ↗ |
| Route | Intramuscular | “Intra muscular injection” NCT01926821 ↗ |